Journal of the Korean Ophthalmological Society 2001;42(11):1594-1599.
Published online November 1, 2001.
Inhibitory Effect of Antibody to alphavbeta5 in Corneal Angiogenesis.
Keun Soo Kim, Ji Wook Yang, Sung Kun Chung, Nam Ho Baek
Department of Ophthalmology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
각막 혈관생성에 있어 αv β5 에 대한 항체의 억제효과
김근수(Keun Soo Kim),양지욱(Ji Wook Yang),정성근(Sung Kun Chung),백남호(Nam Ho Baek)
Abstract
PURPOSE
This study investigated the importance of alphavbeta5 function during vascular endothelial growth factor (VEGF) induced corneal angiogenesis by examining the effects of antibody to alphavbeta5 that blocks alphav 5-mediated cell adhesion to vitronectin. METHODS: A hydrogel disk containing 500 ng of VEGF was implanted into the superior corneal stroma of each of sixteen New Zealand white rabbit eyes. Each eye also received a second hydrogel disk placed adjacent to the first, randomized to contain either 40 g of antibody to alphavbeta5 (n=8) or phosphate-buffered saline (PBS)(n=8). Both disks were positioned 1.2 mm apart from the superior limbus. Eyes were examined daily under a stereomicroscope by two observers and assigned an angiogenesis score based on number and length of new blood vessels. RESULTS: On days 3 through 7 postimplantation, angiogenesis scores were significantly lower in eyes treated with antibody to alphavbeta5 (averaged score=16.33) as compared to eyes treated with PBS (averaged score=26.52)(P<0.05, Wilcoxon signed rank test). CONCLUSIONS: In a rabbit corneal micropocket assay, antibody to alphavbeta5 inhibits corneal angiogenesis induced by VEGF. Substances that target the integrin alphavbeta5 subunit may have therapeutic potential in disorders characterized by ocular neovascularization.
Key Words: Angiogenesis;Corneal micropocket assay;Integrin alphav 5;Vascular endothelial growth factor


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next